课题基金 / 基金详情

项目摘要

项目成果

Ryan A Wilcox的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):t细胞淋巴瘤约占所有非霍奇金淋巴瘤的10%,是异质性的,知之甚少,通常与预后不良有关。大多数t淋巴细胞增生性疾病的起源细胞仍然难以捉摸,这是该领域进一步发展的障碍。正常T细胞在特定转录因子的影响下,在抗原刺激下分化成功能不同的群体。例如,gata结合蛋白3 (GATA-3)是一种控制T细胞向辅助性T细胞2 (Th2)细胞分化的转录因子。我们有
英文摘要
DESCRIPTION (provided by applicant): The T-cell lymphomas, representing approximately 10% of all non-Hodgkin lymphomas, are heterogeneous, poorly understood, and generally associated with a dismal prognosis. The cell of origin for most T-cell lymphoproliferative disorders has remained elusive and represents a barrier to further advances in this field. Normal T cells, under the influence of specific transcription factors, differentiate into functionally disinct populations following antigenic stimulation. For example, GATA-binding protein 3 (GATA-3) is a transcription factor that controls T-cell differentiation into T helper type 2 (Th2) cells. We have shown that myeloid-derived cells are regulated by cytokines transcriptionally regulated by GATA-3 and that these cells, including lymphoma-associated macrophages, promote the growth and survival of malignant T cells. Therefore, we hypothesized that a subset of T-cell lymphomas may be Th2-cell derived and regulate their microenvironment by producing cytokines that are transcriptionally regulated by GATA-3. In support of this hypothesis, we have found that a subset of T-cell lymphomas with an especially poor prognosis expresses GATA-3 and that its expression is associated with clinical and biologic characteristics resembling Th2 cells. Therefore, we aim to test the hypothesis that GATA-3 expression identifies a previously uncharacterized subset of T-cell lymphomas that exploit a GATA-3 driven transcriptional program to regulate lymphoma-associated macrophages within the tumor microenvironment. This hypothesis may support a novel paradigm in tumor biology with implications that extend beyond the T-cell lymphomas. Namely, transcriptional programs that determine cell lineage and differentiation in malignant cells may regulate stromal cells within the tumor microenvironment that are required for tumor growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pacritinib in rel/refr T-cell lymphomas
Pacritinib in rel/refr T-cell lymphomas
Notch and GATA-3 as novel therapeutic targets in T-cell lymphomas
Notch and GATA-3 as novel therapeutic targets in T-cell lymphomas
海外基金